In order to validate the murine CT26 as a relevant CRC model, the LC-MS proteomic analysis of the primary and secondary tumor-bearing murine organs, the spleen and liver, was compared in silico with data of human CRC proteomics published by Chen et al. [46]. This evidence concerns the gene DDX53 and colorectal carcinoma.